Susan Reutzel-Edens

Dr. Susan M. Reutzel-Edens, President of SuRE Pharma Consulting, LLC, earned her Ph.D. in Chemistry at the University of Minnesota under the direction of the late Professor Margaret C. Etter. Over nearly 30 years at Eli Lilly and Company, she led a team of cross-functional scientists charged with finding commercially-viable crystalline forms for small-molecule drug products and served in a strategic scientific leadership role championing R&D innovation across the Small Molecule Design & Development organization. In 2021, she joined the Executive Leadership Team of the Cambridge Crystallographic Data Centre, where for two years she provided strategic scientific oversight of R&D innovation as Head of Science. Upon returning to the U.S., she launched SuRE Pharma Consulting, LLC to provide deep technical expertise in solid-state chemistry in support of all aspects of solid form development to ensure the smooth transition of molecules into medicines. Susan has contributed to the development of more than 150 compounds, is a named inventor on 12 US patents, and has published over 60 papers and book chapters on key aspects of solid form development. Her research interests span diverse topics in organic solid-state chemistry and pharmaceutical materials science, including polymorphism, materials design and engineering, crystallization, solid form screening, physical characterization, structure-property relationships, crystal structure prediction and digital design.